Literature DB >> 30255411

[Improved early diagnostics of rheumatic diseases : Monocentric experiences with an open rheumatological specialist consultation].

A Voigt1, E Seipelt2, H Bastian2, A Juche2, A Krause2.   

Abstract

AIM OF THE PROJECT: To establish an open rheumatological outpatient consultation service for early diagnosis of inflammatory rheumatic diseases and initiation of further diagnostics and treatment.
METHODS: In 2015 an open consultation service was initiated for patients with signs of an early rheumatic disease after referral by primary care physicians. Patients could attend once a week without the need for a prior appointment if they fulfilled at least one of the following criteria: positive rheumatoid factor, increased CRP, anti-CCP antibody or antinuclear antibody, joint pain or back pain for over 3 months, swollen joints, fever of unknown origin or acute muscle pain with or without headache of unknown origin. This article presents the results of the retrospective descriptive data analysis of the first 2 years of this project.
RESULTS: A total of 1262 patients were treated with an average of approximately 20 patients per consultation. In nearly half of the patients an inflammatory rheumatological disease could be diagnosed and immediate diagnostic and treatment measures could be initiated. The diagnostic delay for patients with rheumatoid arthritis was 12 weeks, for patients with polymyalgia rheumatica 11 weeks and for patients with psoriatic arthritis or axial spondylarthritis 18 and 44 weeks, respectively. The time expenditure was a total of 4-5 h per week for an experienced rheumatologist and a specialized rheumatology nurse.
CONCLUSION: Through this open rheumatological outpatient consultation a low threshold opportunity for the early diagnosis of rheumatologic diseases could be established. The diagnostic delay for many rheumatological diseases could be considerably shortened. Cooperation with rheumatologists in private practice guaranteed the subsequent specialized rheumatological care of the identified patients in the early stages of their illness.

Entities:  

Keywords:  Acute consultation service; Early diagnostics; Inflammatory rheumatic disease; Outpatient consultation service; Window of opportunity

Mesh:

Year:  2018        PMID: 30255411     DOI: 10.1007/s00393-018-0540-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  6 in total

1.  2016 update of the EULAR recommendations for the management of early arthritis.

Authors:  Bernard Combe; Robert Landewe; Claire I Daien; Charlotte Hua; Daniel Aletaha; Jose María Álvaro-Gracia; Margôt Bakkers; Nina Brodin; Gerd R Burmester; Catalin Codreanu; Richard Conway; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Joao Fonseca; Karim Raza; Lucía Silva-Fernández; Josef S Smolen; Diana Skingle; Zoltan Szekanecz; Tore K Kvien; Annette van der Helm-van Mil; Ronald van Vollenhoven
Journal:  Ann Rheum Dis       Date:  2016-12-15       Impact factor: 19.103

2.  The discriminative value of inflammatory back pain in patients with persistent low back pain.

Authors:  B Arnbak; O Hendricks; K Hørslev-Petersen; A G Jurik; S J Pedersen; M Østergaard; L T Hermansen; A G Loft; T S Jensen; C Manniche
Journal:  Scand J Rheumatol       Date:  2016-03-16       Impact factor: 3.641

Review 3.  [Evidence-based recommendations on diagnostics and therapy of axial spondyloarthritis : S3 guidelines of the German Society of Rheumatology (DGRh) in cooperation with the Association of the Scientific Medical Societies in Germany (AWMF)].

Authors:  U Kiltz; M Rudwaleit; J Sieper; J Braun
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

4.  [Memorandum of the German Society for Rheumatology on the quality of treatment in rheumatology - Update 2016].

Authors:  A Zink; J Braun; E Gromnica-Ihle; D Krause; H J Lakomek; W Mau; U Müller-Ladner; J Rautenstrauch; C Specker; M Schneider
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

5.  [Medical treatment of rheumatoid arthritis in 2014 : Current data from the German Collaborative Arthritis Centers].

Authors:  K Albrecht; D Huscher; T Eidner; S Kleinert; S Späthling-Mestekemper; S Bischoff; A Zink
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

6.  Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials.

Authors:  Karim Raza; Tajvur P Saber; Tore K Kvien; Paul P Tak; Danielle M Gerlag
Journal:  Ann Rheum Dis       Date:  2012-08-31       Impact factor: 19.103

  6 in total
  3 in total

Review 1.  [Early recognition and screening consultation: a necessary way to improve early detection and treatment in rheumatology? : Overview of the early recognition and screening consultation models for rheumatic and musculoskeletal diseases in Germany].

Authors:  K Benesova; H-M Lorenz; V Lion; A Voigt; A Krause; O Sander; M Schneider; M Feuchtenberger; A Nigg; J Leipe; S Briem; E Tiessen; F Haas; M Rihl; D Meyer-Olson; X Baraliakos; J Braun; A Schwarting; M Dreher; T Witte; G Assmann; K Hoeper; R E Schmidt; P Bartz-Bazzanella; M Gaubitz; C Specker
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

Review 2.  Exploring the therapeutic promise of targeting Rho kinase in rheumatoid arthritis.

Authors:  Anuja Singh; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Vasudevan Mani; Amal M Alsubayiel; Saurabh Bhatia; Ahmed Al-Harrasi; Simona Bungau
Journal:  Inflammopharmacology       Date:  2021-10-26       Impact factor: 4.473

3.  Relationship of serum copper and HLADR4 tissue typing to disease activity and severity in patients with rheumatoid arthritis: A cross sectional study.

Authors:  Khalid Ahmad Omer Aldabbagh; Dashty Abbas Al-Bustany
Journal:  Ann Med Surg (Lond)       Date:  2021-12-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.